Wesfarmers acquired Australian Pharmaceutical Industries Limited (API) on 31 March 2022 by way of a scheme of arrangement. As a result, API shares were suspended from close of trading on the ASX on 22 March 2022 and it was delisted from the ASX on 1 April 2022. API is part of the Health division of Wesfarmers and further information on these businesses can be found here.
View copy of API Scheme Booklet
API TRANSACTION NEWS
- 31.03.22 - Completion of API acquisition
- 21.03.22 - Federal Court approves API Scheme of Arrangement
- 17.03.22 -API Shareholders vote in favour of Scheme of Arrangement
- 11.02.22 -API Scheme Update - ACCC
- 11.02.22 -Acquisition of API - ACCC clearance
- 15.12.21 -API transaction - update
- 08.11.21 -Wesfarmers and API enter into Scheme Implementation Deed
- 07.10.21 -Acquisition of 19.3 per cent stake in API
- 16.09.21 -Proposal to acquire API - update
- 12.07.21 -Proposal to acquire Australian Pharmaceutical Industries
- 12.07.21 -Conditional proposal for API from Wesfarmers
API SHARES
API historicalshareholding details
You can view your historical API shareholding details online through the former API Share Registry website for Boardroom.
Access your API shareholding details online via InvestorServeor contact Boardroom at the contact points listed below.
API Share Registry
Boardroom Pty Limited
Grosvenor Place
Level 12, 225 George Street
Sydney NSW 2000
or
GPO Box 3993
Sydney NSW 2001
Phone: 1300 737 760 (within Australia)
Phone: +61 2 9290 9600 (Internationally)
Fax: +61 2 9290 9655
Email:enquiries@boardroomlimited.com.au
Website:www.boardroomlimited.com.au
API FINANCIAL REPORTS
For investor queries, please contact Investor IRelations@wesfarmers.com.au
